Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B8TK
|
|||
| Former ID |
DIB015082
|
|||
| Drug Name |
LX-6171
|
|||
| Synonyms |
CNS therapeutics, Lexicon; LG617 program, Lexicon
Click to Show/Hide
|
|||
| Indication | Neurological disorder [ICD-11: 6B60] | Phase 2 | [1] | |
| Company |
Lexicon Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H20ClN3O
|
|||
| Canonical SMILES |
C1CN(CCC1C(=O)C2=CC=C(C=C2)C3=CC(=CC=C3)Cl)C4=NC=CC=N4
|
|||
| InChI |
1S/C22H20ClN3O/c23-20-4-1-3-19(15-20)16-5-7-17(8-6-16)21(27)18-9-13-26(14-10-18)22-24-11-2-12-25-22/h1-8,11-12,15,18H,9-10,13-14H2
|
|||
| InChIKey |
VHTIWIZIPOXSNP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 914808-66-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00691808) Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.